| J0178 | Injection, aflibercept, 1 mg | 780 | $690 | $540.2K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 2,520 | $30 | $73.1K |
| J2778 | Injection, ranibizumab, 0.1 mg | 320 | $180 | $56.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 690 | $80 | $55.5K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 600 | $90 | $52.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,410 | $20 | $25.4K |
| J3590 | Unclassified biologics | 140 | $60 | $8.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $110 | $5.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 20 | $60 | $1K |
| 76512 | The provider uses B–scan ultrasound imaging, with or without a non–qualitative A–scan superimposed, to examine the intraocular and orbital structures. | 20 | $30 | $610 |